Biological material taken from adipose tissue, and preparation method and application of biological material
A biomaterial, adipose tissue technology, used in tissue regeneration, oil/fat/wax inactive ingredients, drug combinations, etc., can solve problems such as unclear cell components, reduce side effects, remove immunogenicity, and high safety Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Example 1 Preparation of Biomaterials from Adipose Tissue
[0038] The fat was obtained from the patient under the condition of obtaining informed consent. The fat obtained by suction or surgical resection was shredded and rinsed three times with normal saline, placed in a 50ml centrifuge tube, and placed in a centrifuge at 1,200r / rpm After centrifuging for 3 minutes, drain the excess liquid at the bottom and the uppermost layer of fat, collect the fat in the middle layer, and obtain the crude fat product. The crude fat was mechanically emulsified by two 10ml injection syringes connected with a three-way pipe at an average speed of 60 to 120 times to obtain nano fat. Then put the nano-fat into a 50ml test tube, centrifuge at 1,500 / rpm for 5 minutes, collect the transparent liquid in the middle layer, and obtain it.
[0039] Or freeze the nanofat in a -80°C refrigerator (or liquid nitrogen), then thaw in a 37°C water bath, repeat freezing and thawing once or twice, cent...
Embodiment 2
[0041] The growth factor detection that embodiment 2 biological material contains
[0042] The obtained fat extract was used to detect the content of growth factors, including IGF-1, BDNF, GDNF, TGF-β, HGF, VEGF, bFGF, PDGF, EGF, NT-3, GH and GM, using ELISA immunosorbent assay kit - Cytokines such as CSF.
[0043] ELISA analysis was carried out on the biomaterials obtained from fats from three donors, and the results showed that IGF-1 (11400±2300pg / mL), BDNF (1860±500pg / mL), GDNF (1820±430pg / mL) in the biomaterials were analyzed by ELISA. ), TGF-β(1020±680pg / mL), HGF(685±384pg / mL), VEGF(229±23pg / mL), bFGF(229±67pg / mL), PDGF(175±30pg / mL) and EGF (139±99pg / mL) is relatively high, and contains trace amounts of NT-3, GH and GM-CSF (see figure 1 ).
Embodiment 3
[0044] Example 3 Effects of Biomaterials on the Proliferation of Human Umbilical Vein Endothelial Cells
[0045] Human umbilical vein endothelial cells (Sciencell, U.S.) were added with high-glucose DMEM (Gibco, U.S.) to make a cell suspension, and then inoculated in high-glucose DMEM medium containing 10% fetal bovine serum (HYCLONE, U.S.) , Passed once every 3 days, and the 3rd and 4th passage cells were used in the experiment.
[0046] Human umbilical vein endothelial cells were inoculated on a 96-well plate at a density of 1000 cells per well, and fat extracts of different concentrations (1v / v%, 2v / v% and 5v / v%) were added, each concentration was set at 6 After culturing for 72 hours, CCK8 kit (Beyotime Company, USA) was used to detect cell proliferation and determine the OD value. The experiment was repeated three times to obtain the average value and standard deviation.
[0047] 72 hours after the cells were treated with biological materials, the number of cells detecte...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com